Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.
Vinay Prasad is tightening the screws at the FDA, overruling staff and signaling a tougher stance on vaccines and gene ...
Some pharmaceutical companies not targeted by President Trump for agreements to lower U.S. drug pricing aim to craft their ...
Prasad changed jobs but his conservative regulatory doctrine remains the same, particularly for cell and gene therapies. The ...
Talkiatry, a virtual psychiatry company, announced Thursday it raised $210 million as it looks to build on its ...
BridgeBio Pharma’s experimental drug for the most common cause of dwarfism accelerated children’s growth in a pivotal ...
Digital therapeutics developer Big Health announced Thursday that it has raised $23.7 million from notable investors betting ...
Today, we’ve got a ton of updates including news about venture capital funding, telehealth policy, the government’s progress ...
Medicaid cuts in the tax bill Republicans passed last summer are expected to hit rural providers and patients especially hard. Much of those cuts are the result of restrictions on some of the ways ...
Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...
In the United States and elsewhere, there’s been a major shift in patients treated for lung cancer. As the percentage of ...
In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results